Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
botulinum toxin type A |
| gptkbp:administeredBy |
injection
|
| gptkbp:alternativeTo |
gptkb:Botox
gptkb:Dysport gptkb:Xeomin |
| gptkbp:approvalYear |
2019
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
M03AX01
|
| gptkbp:chemicalClass |
gptkb:protein
|
| https://www.w3.org/2000/01/rdf-schema#label |
Jeuveau
|
| gptkbp:indication |
aesthetic treatment
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
Evolus, Inc.
|
| gptkbp:mechanismOfAction |
blocks acetylcholine release at neuromuscular junction
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:sideEffect |
headache
injection site pain eyelid ptosis |
| gptkbp:usedFor |
treatment of moderate to severe glabellar lines
|
| gptkbp:bfsParent |
gptkb:Botulinum_toxin
|
| gptkbp:bfsLayer |
6
|